Notice: This company has been marked as potentially delisted and may not be actively trading. Audentes Therapeutics (BOLD) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Guggenheim Downgrades Boundless Bio (BOLD)December 14, 2024 | msn.comBoundless Bio Announces Pipeline and Leadership UpdatesDecember 12, 2024 | globenewswire.comBoundless Bio to Participate in the Piper Sandler Healthcare ConferenceNovember 25, 2024 | globenewswire.comBoundless Bio Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 7, 2024 | globenewswire.comBoundless Bio to Participate in the 2024 Guggenheim Global Healthcare ConferenceNovember 5, 2024 | globenewswire.comBoundless Bio to Participate in the 2024 Cantor Global Healthcare ConferenceSeptember 11, 2024 | globenewswire.comGene therapy firm to close California site, shift projects to $100M Sanford facilitySeptember 7, 2024 | bizjournals.comKim Kardashian's Bold Hair Makeover Is Turning HeadsSeptember 2, 2024 | newsweek.comBoundless Bio Inc. Common StockAugust 21, 2024 | 247wallst.comBoundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial ResultsAugust 12, 2024 | globenewswire.comBoundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceJune 5, 2024 | businesswire.comBoundless Bio Reports First Quarter 2024 Financial Results and Corporate HighlightsMay 13, 2024 | businesswire.comBoundless Bio to Present at the Citizens JMP Life Sciences Conference 2024May 6, 2024 | businesswire.comMalignant Ascites Market to Observe Growth at a CAGR of 1.2% by 2034 | DelveInsightApril 30, 2024 | finance.yahoo.comBOLD Boundless Bio, Inc.April 26, 2024 | seekingalpha.comBold GirlsApril 11, 2024 | bbc.co.ukBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsApril 11, 2024 | businesswire.comBoundless Bio Inc BOLDApril 11, 2024 | morningstar.comBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024April 8, 2024 | businesswire.comBoundless Bio Announces Pricing of Initial Public OfferingMarch 27, 2024 | businesswire.comMarriott Bonvoy Bold credit card review 2023November 25, 2023 | cnn.comKristen Louelle Is Bold and Beautiful in These 4 Pics in Atlantic CityNovember 4, 2023 | yahoo.comWhat Top 25 upsets are coming this weekend? Bold predictions for Week 5 in college footballOctober 27, 2023 | usatoday.comHow Bold Leadership Can Help Or Hurt YouApril 27, 2023 | forbes.comBold Therapeutics Presents Jaw-Dropping Interim Phase 2 Clinical Data for BOLD-100 in the Treatment of Advanced Colorectal Cancer at AACR 2023April 23, 2023 | finance.yahoo.comThe Benefits of Bold Leadership and How Leaders Can Develop a Bold MindsetApril 18, 2023 | entrepreneur.comFive bold predictions for the men's NCAA Tournament's Final FourApril 2, 2023 | usatoday.comMen's NCAA Tournament 2023: 10 bold predictions for March MadnessMarch 26, 2023 | usatoday.com5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough ScienceMarch 23, 2023 | finance.yahoo.comTikTok Has A New ‘Bold Glamour’ AI-Powered Filter, Here Are The RisksMarch 17, 2023 | forbes.comYou but better? Not so fast. Unpacking TikTok's controversial 'Bold Glamour' filterMarch 12, 2023 | yahoo.comOn King's holiday, daughter calls for bold action over wordsJanuary 18, 2023 | news.yahoo.comIt's blue Monday... Let's embrace it says JO ELVIN, with this season's refreshingly bold take on the colourJanuary 17, 2023 | dailymail.co.ukPersonal And Career Success One Bold Move A DayJanuary 13, 2023 | forbes.comLeBron exits LA and an American F1 star: our bold sports predictions for 2023January 5, 2023 | theguardian.comBold predictions for college football's Week 11 have Alabama and LSU on upset alertNovember 14, 2022 | usatoday.comLEGO makes bold claim on how bricks affect mental healthOctober 8, 2022 | nypost.comBOLD_old Historical DataAugust 24, 2022 | investing.comFDA approves first fast-acting oral drug for clinical depressionAugust 22, 2022 | yahoo.comAppnovation Earns Seven 2022 MUSE Creative AwardsMarch 18, 2022 | yahoo.comNemours Children's Health Officially Launches New Brand to Advance Children's HealthSeptember 16, 2021 | finance.yahoo.comAstellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical HoldSeptember 14, 2021 | feeds.benzinga.com Get Audentes Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast. Click here for the ticker >>> BOLD Media Mentions By Week BOLD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BOLD News Sentiment▼0.000.60▲Average Medical News Sentiment BOLD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BOLD Articles This Week▼00▲BOLD Articles Average Week Get Audentes Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Acrivon Therapeutics News Today Aclaris Therapeutics News Today Biomea Fusion News Today XBiotech News Today Verastem News Today LifeVantage News Today Silence Therapeutics News Today MacroGenics News Today Precigen News Today Cybin News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BOLD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Audentes Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Audentes Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BOLD Stock Alerts